Literature DB >> 19578105

The causes and clinical significance of fever in systemic lupus erythematosus: a retrospective study of 487 hospitalised patients.

W J Zhou1, Cheng-De Yang.   

Abstract

The causes of fever in systemic lupus erythematosus (SLE) are complicated. Differential diagnosis of fever in SLE is crucial for optimal management of these patients. To better understand the causes and characteristics of fever in SLE, the medical records of 1949 consecutive patients hospitalised for SLE from January 2002 to May 2007 were reviewed. A total of 487 SLE-hospitalised patients with fever were identified and retrospectively analysed. Among them, 265 patients had fever from infection, 206 had fever related to SLE, 8 had fever caused by both SLE activity and infections, 4 had fever caused by malignancies and 4 had fever ascribed to miscellaneous causes. The most common sites of infection were the respiratory tract (62.6%), urinary tract (8.6%), skin and mucosa (8.3%). A prednisone dose of <or=100 mg/d was able to suppress SLE fever in 80.6% of the patients, usually within 1-5 days. Compared to patients with infection fever, those with SLE fever were more likely to have lower serum complement C3 and a higher SLE Disease Activity Index score. Infection fever was found to be associated with the use of azathioprine within the last six months. In conclusion, infection and disease activity are the most common causes of fever in SLE. Those patients for whom SLE fever could not be suppressed by a higher dose of steroids usually had severe lupus encephalopathy or hemophagocytic syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578105     DOI: 10.1177/0961203309103870

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

1.  New classification criteria for systemic lupus erythematosus.

Authors:  Martin Aringer; Michelle Petri
Journal:  Curr Opin Rheumatol       Date:  2020-11       Impact factor: 5.006

Review 2.  Febrile conditions in rheumatology.

Authors:  E Tóth; G Speer
Journal:  Clin Rheumatol       Date:  2012-08-26       Impact factor: 2.980

3.  Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan.

Authors:  Shih-Chao Kang; Shinn-Jang Hwang; Yu-Sheng Chang; Chung-Tei Chou; Chang-Youh Tsai
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

4.  Prevalence of connective tissue diseases in egyptian patients presenting with Fever of unknown origin.

Authors:  Mohamad S Abdelbaky; Howaida E Mansour; Shafika I Ibrahim; Iman A Hassan
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2011-05-09

Review 5.  Cutaneous mucormycosis in a patient with lupus nephritis: A case report and review of literature.

Authors:  Wenrong Cheng; Guoqin Wang; Min Yang; Lijun Sun; Hongrui Dong; Yipu Chen; Hong Cheng
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

6.  Anakinra for Recurrent Fevers in Systemic Lupus Erythematosus.

Authors:  Eric Dein; Ashley Ingolia; Caoilfhionn Connolly; Rebecca Manno; Homa Timlin
Journal:  Cureus       Date:  2018-12-27

Review 7.  Tocilizumab therapy for persistent high-grade fever in systemic lupus erythematosus: two cases and a literature review.

Authors:  Ma Chaoyi; Bikash Shrestha; Li Hui; Ding Qiujin; Fu Ping
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

Review 8.  Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review.

Authors:  Juan Sebastián Peinado-Acevedo; Diana-Cristina Varela; Alicia Hidrón
Journal:  Rheumatol Int       Date:  2020-11-04       Impact factor: 2.631

Review 9.  Fevers in Adult Lupus Patients.

Authors:  Homa Timlin; Abrahim Syed; Uzma Haque; Brittany Adler; Genevieve Law; Kirthi Machireddy; Rebecca Manno
Journal:  Cureus       Date:  2018-01-22

Review 10.  Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome.

Authors:  Puja Mehta; Randy Q Cron; James Hartwell; Jessica J Manson; Rachel S Tattersall
Journal:  Lancet Rheumatol       Date:  2020-05-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.